Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model

Neurochemistry International

Volumn 65, Issue 1, 2014, Pages 1-13

  Yadav, Satyndra Kumar ^a   Prakash, Jay ^a   Chouhan, Shikha ^a   Westfall, Susan ^a   Verma, Mradul ^a   Singh, Tryambak Deo ^a   Singh, Surya Pratap ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Dopamine; Estrogen; GFAP; iNOS; MPTP; Mucuna pruriens; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; ALCOHOL; DOPAMINE; ESTROGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HOMOVANILLIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; MACUNA PRURIENS EXTRACT; MALONALDEHYDE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRITE; PLANT EXTRACT; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOWN REGULATION; DRUG MEGADOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LD 50; LIPID PEROXIDATION; MALE; MICROGLIA; MOUSE; MOUSE MODEL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PLANT SEED; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAROD TEST; SUBSTANTIA NIGRA; VELVET BEAN;

DOPAMINE; ESTROGEN; GFAP; INOS; MPTP; MUCUNA PRURIENS; PARKINSON'S DISEASE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; ESTROGENS; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MICE; MUCUNA; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; PARKINSON DISEASE; PHYTOTHERAPY; PLANT EXTRACTS; SEEDS;

EID: 84891536480     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.12.001     Document Type: Article

References (69)

1. Y.A. Adebowale, A. Adeyemi, and A.A. Oshodi Variability in the physicochemical, nutritional and antinutritional attributes of six Mucuna species Food Chem. 89 2005 37 48 (Pubitemid 39024480)
2. A. Alonso, H. Gonzalez-Pardo, P. Garrido, N.M. Conejo, P. Llaneza, F. Diaz, C.G. Del Rey, and C. Gonzalez Acute effects of 17 beta-estradiol and genistein on insulin sensitivity and spatial memory in aged ovariectomized female rats Age (Dordr) 32 2010 421 434
3. Z. Arral, T. Amit, B.H.M. youdim, and R. Farah Lithium and oxidative stress lessons from the MPTP model of Parkinson's disease Neurosci. Lett. 1 2012 57 61
4. M. Baldereschi, A. Di Carlo, W. Rocca, P. Vanni, S. Maggi, E. Perissinotto, F. Grigoletto, L. Amaducci, and D. Inzitari Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men Neurology 55 2000 1358 1363
5. A.M. Baraka, A.A. Korish, G.A. Soliman, and H. Kamal The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease Life Sci. 88 2011 879 885
6. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury nitric oxide and superoxide Proc. Natl. Acad. Sci. USA 87 1990 1620 1624
7. M. Benedetti, D. Maraganore, J. Bower, S. McDonnell, B. Peterson, J. Ahlskog, D. Schaid, and W. Rocca Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case control study Mov. Disord. 16 2001 830 837 (Pubitemid 36041184)
8. D. Blum, S. Torch, N. Lambeng, M. Nissou, A. Benabid, R. Sadoul, and J. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172 (Pubitemid 32524182)
9. A.R. Butler, F.W. Flitney, and D.L.H. Williams NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemists perspective Trends Pharmacol. Sci. 16 1995 18 22
10. S. Chouhan, j. Prakash, S.K. Yadav, N.K. Agrawal, and S.P. Singh Effect of bisphenol A on fertility of male mice J. Sci. Res. 57 2013 77 84
11. C.X. Chun, C. Ying, Z.Y. Gui, F. Fang, and C.L. Min Protective effect of ginsenoside Rg1 against MPTP induced apoptosis in mouse substantia nigra neurons Acta Pharmacol. Sin. 23 82 2002 9 834
12. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
13. D.J. Ecobichon The Basis of Toxicology Testing 1997 CRC Press New York pp. 43
14. E.D. Eze, A. Mohammed, K.Y. Musa, and Y. Tanko Evaluation of effect of ethanolic leaf extract of Mucuna pruriens on blood glucose levels in alloxan-induced diabetic wistar rats Asian J. Med. Sci. 4 2011 23 28
15. C. Fendri, A. Mechri, G. Khiari, A. Othman, A. Kerkeni, and L. Gaha Oxidative stress involvement in schizophrenia pathophysiology: a review L'Encéphale 32 2006 244 252 (Pubitemid 43670234)
16. P.O. Fernagut, E. Diguet, B. Labattu, and F. Tison A simple method to asses stride length as an index of nigrostriatal dysfunction in mice J Neurosci Methods. 113 2013 123 130
17. D.L. Granger, R.R. Taintor, K.S. Boockvar, and J.B. Hibbs Measurement of nitrate and nitrite in biological samples using nitrate reductase and Greiss reaction Methods Enzymol. 268 1996 142 151 (Pubitemid 26286356)
18. S.P. Gupta, S. Patel, S. Yadav, A.K. Singh, S. Singh, and M.P. Singh Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation? Neurochem. Res. 35 2010 1206 1213
19. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine third ed. 1999 Oxford University Press London
20. S. Hara, T. Endo, F. Kuriiwa, and S. Kano Mechanism of PQ-stimulated lipid peroxidation in mouse brain and pulmonary microsomes J. Pharm. Pharmacol. 43 1991 731 733
21. H. Hinterberger The biochemistry of catecholamine in relation to Parkinson's disease Aust. NZ. J. Med. 1 1971 14 18
22. R. Hishika, S. Shastry, S. Shinde, and S.S. Guptal Preliminary, phytochemical and anti-inflammatory activity of seeds of Mucuna pruriens Indian J. Pharmacol. 13 1981 97
23. H. Ischiropoulos, L. Zhu, J. Chen, M. Tsai, J.C. Martin, C.D. Smith, and J.S. Beckman Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase Arch. Biochem. Biophys. 298 1992 431 437
24. V. Jackson-Lewis, and R.J. Smeyne MPTP and SNpc DA neuronal vulner-ability: role of dopamine, superoxide and nitric oxide in neurotoxicity Neurotoxicol. Res. 7 2005 193 202
25. G.M. Jones, and J.A. Vale Mechanisms of toxicity, clinical features, and management of diquat poisoning: a review J. Toxicol. Clin. Toxicol. 38 2000 123 128 (Pubitemid 30212833)
26. S. Kasture, S. Pontis, A. Pinna, N. Schintu, L. Spina, R. Longoni, N. Simola, M. Ballero, and M. Morelli Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease Neurotox. Res. 15 2009 111 122
27. R. Katzenschlager, A. Evans, A. Manson, P.N. Patsalos, N. Ratnaraj, H. Watt, L. Timmerman, R. Van der Giessen, and A.J. Lees Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study J. Neurosurg. Psychiatry 75 2004 1672 1677 (Pubitemid 39611463)
28. C. Kim, M.B. Speisky, and S.N. Kharouba Rapid and sensitive method for measuring norepinephrin, dopamine, 5-hydroxytryp-tamine and their major metabolites in rat brain by high performance liquid chromatography J. Chromatogr. 386 1987 25 35
29. S. Krishnamurthy, D. Garabadu, N.R. Reddy, and K.P. Joy Risperidone in ultra low dose protects against stress in the rodent cold restraint model by modulating stress pathways Neurochem. Res. 36 2011 1750 1758
30. J.M. Lee, D.S. Hwanga, H.G. Kim, C.H. Lee, and M.S. Oh Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced neurotoxicity under postmenopausal conditions J. Ethnopharmacol. 139 2012 883 888
31. O.H. Lowry, N.J. Rosenborough, and A.L. Farr Protein measurement with folin phenol reagent J. Biol. Chem. 193 1951 265 275
32. D.G. Machado, V.B. Neis, G.O. Balen, A. Colla, M.P. Cunha, J.B. Dalmarco, M.G. Pizzolatti, R.D. Prediger, and A.L.S. Rodrigues Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice. Evidence for the involvement of the dopaminergic system Pharmacol. Biochem. Behav. 103 2012 204 211
33. S. Manna, D. Bhattacharyya, T.K. Mandal, and S. Dey Neurophar-macological effects of deltamethrin in rats J. Vet. Sci. 7 2006 133 136
34. B.V. Manyam, and K.M. Parikh Anti-parkinson activity of Mucuna pruriens seed Ann. Neurosci. 9 2002 40 46
35. B.V. Manyam, M. Dhanasekaran, and T.A. Hare Neuroprotective effects of the antiparkinson drug Mucuna pruriens Phytother. Res. 9 2004 706 712 (Pubitemid 39481688)
36. K.S. McNaught, D.P. Perl, A.L. Brownell, and C.W. Olanow Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease Ann. Neurol. 56 2004 149 162 (Pubitemid 38857373)
37. L. Misra, and H. Wagner Alkaloidal constituents of Mucuna pruriens seeds Phytochemistry 65 2004 2565 2567 (Pubitemid 39286618)
38. M. Mohanasundari, M.S. Srinivasan, S. Sethupathy, and M. Sabesan Enhanced neuroprotective effect by combination of bromocriptine and hypericum perforatum extract against MPTP-induced neurotoxicity in mice J. Neurol. Sci. 249 2006 140 144 (Pubitemid 44665916)
39. M.C. Morale, P.A. Serra, F.L. Episcopo, C. Tirolo, S. Caniglia, N. Testa, F. Gennuso, G. Giaquinta, G. Rocchitta, M.S. Desole, E. Miele, and B. Marchetti Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration Neuroscience 138 2006 869 878
40. M.S. Moron, J.W. Depierre, and B. Mannervik Levels of glutathione, glutathione reductase and glutathione S-transferaseactivities inrat lungand liver Biochim. Biophys. Acta 582 1979 67 78 (Pubitemid 9065588)
41. C. Mytilineou, and L. Friedman Studies on the metabolism and toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultures of embryonic rat mesencephalon J. Neurochem. 51 1988 750 755
42. M.Di. Napoli, I.M. Shah, and D.A. Stewart Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside Expert Rev. Neurother. 7 2007 1693 1729 (Pubitemid 350262714)
43. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358 (Pubitemid 9194347)
44. Pant, M.C., Joshi, L.D., 1970. Identification of pharmacologically active substances in the seeds of Mucuna pruriens (Abs). Proceedings of the Annual Conference of Indian Pharmacological Society, Lucknow, India. Indian J. Pharmacol. 2, 24.
45. T.L. Perry, D.V. Godin, and S. Hansen Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33 1982 305 310 (Pubitemid 13119539)
46. M.A. Piggott, E.F. Marshall, N. Thomas, S. Lloyd, C.A. Court, E. Jaros, D. Burn, M. Johnson, R.H. Perry, I.G. McKeith, C. Ballard, and E.K. Perry Striatal dopaminergic markers in dementia with lewy bodies. Alzheimer's disease and Parkinson's diseases rostracaudal distribution Brain 122 1999 1449 1468 (Pubitemid 29374123)
47. J. Prakash, S.K. Yadav, S. Chouhan, and S.P. Singh Neuroprotective role of withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism Neurochem. Res. 38 2013 972 980
48. J. Prakash, S.K. Yadav, S. Chouhan, S. Prakash, and S.P. Singh Synergistic effect of Mucuna pruriens and Withania somnifera in a Parkinsonian mouse model developed by paraquat Adv. Biosci. Biotechnol. 4 2013 1 9
49. A. Quesada, and P.E. Micevych Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions J. Neurosci. Res. 75 2004 107 116 (Pubitemid 38049411)
50. A.P. Raina, and R. Khatri Quantitativ e determination of L-DOPA in Seeds of Mucuna pruriens germplasm by high performance thin layer chromatography Indian J. Pharm. Sci. 73 2011 459 462
51. S. Rajasankar, T. Manivasagam, A. Krishnamurti, and M. Ramanathan The neuroprotective effect of withania somnifera root extract in MPTP-intoxicated mice. An analysis of behavioral and biochemical variables Cell. Mol. Biol. Lett. 12 2007 473 481
52. S. RajaSankar, T. Manivasagam, V. Sankar, S. Prakash, R. Muthusamy, A. Krishnamurti, and S. Surendran Withania somniferaroot extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse J. Ethnopharmacol. 125 2009 369 373
53. P.S. Shahaji, and S.A. Parnu Estrogenic activity of Mucuna pruriens in Swiss albino mice Int. J. Pharm. 2 2011 4
54. A.H. Schapira Mitochondria in the aetiology and pathogenesis of Parkinson's disease Lancet Neurol. 7 2008 97 109 (Pubitemid 350251942)
55. N.A. Seniuk, W.G. Tatton, and C.E. Greenwood Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP Brain Res. 527 1990 7 20 (Pubitemid 20290579)
56. A. Siderowf, and M. Stern Update on Parkinson disease Ann. Intern. Med. 138 2003 651 658 (Pubitemid 38124657)
57. P. Siddhuraju, K. Vijayakumari, and K. Janardhanan Chemical composition and protein quality of the little known legume, velvet bean (Mucuna pruriens (L.) DC.) J Agric. Food Chem. 44 1996 2636 2641 (Pubitemid 126453553)
58. A.K. Singh, M.N. Tiwari, A. Dixit, G. Upadhyay, D.K. Patel, D. Singh, O. Prakash, and M.P. Singh Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and independent regulations Toxicol. Sci. 122 2011 526 538
59. S. Singh, K. Singh, D.K. Patel, C. Singh, C. Nath, V.K. Singh, R.K. Singh, and M.P. Singh The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6- tetrahydropyridineinduced Parkinson's disease phenotype and nicotine-mediated neuroprotection Rejuvenation Res. 12 2009 185 197
60. X. Song, S. Perkins, B.S. Jortner, and M. Ehrich Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells Neurotoxicol. 18 1997 341 353
61. S. Surendran Neurochemistry of metabolic diseases-lysosomal storage diseases Phenylketonuria and Canavan Disease 2007 Transworld Research Network India
62. C.M. Tanner, and S.M. Goldman Epidemiology of Parkinson's disease Neurol. Clin. 14 1996 317 335 (Pubitemid 26157425)
63. Y.B. Tripathi, and A.K. Upadhyay Antioxidant property of Mucuna pruriens Linn Curr. Sci. 80 2001 11
64. K.L. Tsang, S.L. Ho, and S.K. Lo Estrogen improves motor disability in Parkinsonian postmenopausal women with motor fluctuations Neurology 54 2000 2292 2298
65. R.A. Vaidya, S.D. Allorkar, A.R. Seth, and S.K. Panday Neurology 26 1978 179 186
66. S.K. Van Den Eeden, C.M. Tanner, A.L. Bernstein, R.D. Fross, A. Leimpeter, D.A. Bloch, and L.M. Nelson Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity Am. J. Epidemiol. 157 2003 1015 1022 (Pubitemid 36628805)
67. A. van der Vliet, C.A. O' Neill, B. Haliwell, C.E. Cross, and H. Kaur Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitirite. Evidence for hydroxyl radical production from peroxynitrite FEBS Lett. 339 1994 89 92
68. M. Weber, and M. Mapstone Memory complaints and memory performance in the menopausal transition Menopause 16 2009 694 700
69. S.K. Yadav, J. Prakash, S. Chouhan, and S.P. Singh Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model Neurochem. Int. 62 2013 1039 1047